ES2105798T3 - Amidas de acido sulfonamidocarbonilpiridin-2-carboxilico asi como sus piridin-n-oxidos, procedimiento para su preparacion y su empleo como medicamento. - Google Patents

Amidas de acido sulfonamidocarbonilpiridin-2-carboxilico asi como sus piridin-n-oxidos, procedimiento para su preparacion y su empleo como medicamento.

Info

Publication number
ES2105798T3
ES2105798T3 ES95103581T ES95103581T ES2105798T3 ES 2105798 T3 ES2105798 T3 ES 2105798T3 ES 95103581 T ES95103581 T ES 95103581T ES 95103581 T ES95103581 T ES 95103581T ES 2105798 T3 ES2105798 T3 ES 2105798T3
Authority
ES
Spain
Prior art keywords
sulfonamidocarbonylpiridin
piridin
oxides
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95103581T
Other languages
English (en)
Inventor
Klaus Dr Weidmann
Martin Dr Bickel
Volkmar Dr Gunzler-Pukall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2105798T3 publication Critical patent/ES2105798T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A SULFONAMIDO CARBONILPIRIDINA 2 AMIDA ACIDO CARBOXILICO Y SU OXIDO N - PIRIDINA, SEGUN LA FORMULA GENERAL I LOS COMPUESTOS CONOCIDOS ENCUENTRAN UTILIZACION COMO MEDICAMENTO CONTRA ENFERMEDADES FIBROTICAS, COMO ELEMENTOS FIBROSUPRESIVOS Y COMO INHIBIDORES DE PROLILHIDROXILASA Y DE LA BIOSINTESIS DE COLAGENO.
ES95103581T 1994-03-25 1995-03-13 Amidas de acido sulfonamidocarbonilpiridin-2-carboxilico asi como sus piridin-n-oxidos, procedimiento para su preparacion y su empleo como medicamento. Expired - Lifetime ES2105798T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4410423A DE4410423A1 (de) 1994-03-25 1994-03-25 Sulfonamidocarbonylpyridin-2-carbonsäureamide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ES2105798T3 true ES2105798T3 (es) 1997-10-16

Family

ID=6513863

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95103581T Expired - Lifetime ES2105798T3 (es) 1994-03-25 1995-03-13 Amidas de acido sulfonamidocarbonilpiridin-2-carboxilico asi como sus piridin-n-oxidos, procedimiento para su preparacion y su empleo como medicamento.

Country Status (19)

Country Link
US (1) US5610172A (es)
EP (1) EP0673931B1 (es)
JP (1) JPH07278109A (es)
KR (1) KR950032124A (es)
CN (1) CN1114312A (es)
AT (1) ATE156815T1 (es)
AU (1) AU689199B2 (es)
CA (1) CA2145476A1 (es)
CZ (1) CZ287768B6 (es)
DE (2) DE4410423A1 (es)
DK (1) DK0673931T3 (es)
ES (1) ES2105798T3 (es)
FI (1) FI951386L (es)
GR (1) GR3024860T3 (es)
HU (1) HUT72059A (es)
NO (1) NO304308B1 (es)
NZ (1) NZ270783A (es)
PL (1) PL180042B1 (es)
ZA (1) ZA952408B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191368B1 (en) 1995-09-12 2001-02-20 Tessera, Inc. Flexible, releasable strip leads
EP2295060B1 (en) 2001-12-06 2018-10-31 Fibrogen, Inc. Treatment or prevention of ischemic or hypoxic conditions
CN102526045A (zh) * 2001-12-06 2012-07-04 法布罗根股份有限公司 提高内源性红细胞生成素(epo)的方法
US20040158289A1 (en) * 2002-11-30 2004-08-12 Girouard Steven D. Method and apparatus for cell and electrical therapy of living tissue
US8124582B2 (en) 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
US7618940B2 (en) 2002-12-06 2009-11-17 Fibrogen, Inc. Fat regulation
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US7764995B2 (en) * 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US7729761B2 (en) * 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
US7828711B2 (en) * 2004-08-16 2010-11-09 Cardiac Pacemakers, Inc. Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
US8060219B2 (en) * 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
ATE470439T1 (de) 2005-06-15 2010-06-15 Fibrogen Inc Verwendung von hif 1alfa modulatoren zur behandlung von krebs
US7774057B2 (en) 2005-09-06 2010-08-10 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression for cardiac protection
KR100959538B1 (ko) * 2006-03-30 2010-05-27 엘지전자 주식회사 비디오 신호를 디코딩/인코딩하기 위한 방법 및 장치
NZ601730A (en) 2006-06-26 2014-04-30 Akebia Therapeutics Inc Prolyl hydroxylase inhibitors and methods of use
WO2009002533A1 (en) * 2007-06-27 2008-12-31 The Brigham And Women's Hospital, Inc. Inflammatory bowel disease therapies
NO2686520T3 (es) 2011-06-06 2018-03-17
SMT202400092T1 (it) 2013-06-13 2024-05-14 Akebia Therapeutics Inc Composizioni e metodi per il trattamento dell'anemia
EP3578546A1 (en) 2013-11-15 2019-12-11 Akebia Therapeutics Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
HK1247201A1 (zh) 2015-01-23 2018-09-21 阿克比治疗有限公司 2-(5-(3-氟苯基)-3-羟基吡啶甲醯胺)乙酸的固体形式、其组合物及用途
PL3277270T3 (pl) 2015-04-01 2022-02-14 Akebia Therapeutics, Inc. Kompozycje i sposoby leczenia niedokrwistości
CA3097219A1 (en) 2018-05-09 2019-11-14 Akebia Therapeutics, Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid
US12612367B2 (en) 2019-12-10 2026-04-28 Akebia Therapeutics, Inc. Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW352384B (en) * 1992-03-24 1999-02-11 Hoechst Ag Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals

Also Published As

Publication number Publication date
CZ73395A3 (en) 1995-11-15
HUT72059A (en) 1996-03-28
ZA952408B (en) 1995-11-27
NO951146L (no) 1995-09-26
FI951386A7 (fi) 1995-09-26
ATE156815T1 (de) 1997-08-15
FI951386L (fi) 1995-09-26
US5610172A (en) 1997-03-11
AU1504295A (en) 1995-10-05
DK0673931T3 (da) 1998-03-16
HU9500865D0 (en) 1995-05-29
DE59500488D1 (de) 1997-09-18
FI951386A0 (fi) 1995-03-23
PL307848A1 (en) 1995-10-02
JPH07278109A (ja) 1995-10-24
NO951146D0 (no) 1995-03-24
NZ270783A (en) 1997-02-24
GR3024860T3 (en) 1998-01-30
EP0673931A1 (de) 1995-09-27
KR950032124A (ko) 1995-12-20
CA2145476A1 (en) 1995-09-26
PL180042B1 (en) 2000-12-29
CN1114312A (zh) 1996-01-03
HK1012338A1 (en) 1999-07-30
DE4410423A1 (de) 1995-09-28
CZ287768B6 (en) 2001-01-17
EP0673931B1 (de) 1997-08-13
NO304308B1 (no) 1998-11-30
AU689199B2 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
ES2146676T3 (es) Amidas de esteres de acido sulfonamidocarbonilpiridin-2-carboxilico asi como sus piridin-n-oxidos, procedimiento para su preparacion y su empleo como medicamentos.
TR200101513T2 (tr) Benzamid türevleri ve bunların APOB-100 salgılama inhibitörleri olarak kullanımları
MY100343A (en) Amide derivative and external medicament comprising same
FR2360587A1 (fr) Nouveaux derives d'amino-alcoyl-furannes utiles comme medicaments
ES542319A0 (es) Un procedimiento para la preparacion de derivados de la 2 pirimidinil-1-piperazina
FR2432511A1 (fr) Derives triazoliques, leur preparation et leur application en tant que medicaments
ES2095824T3 (es) Procedimiento para la obtencion de derivados de n-2'-(aminofenil)-benzamida y su empleo para la lucha contra las enfermedades neoplasticas.
ES2183180T3 (es) Nuevos derivados de guanidina, procedimientos para su preparacion y su uso como medicamento.
FR2416888A1 (fr) Nouveaux derives de phenyl-piperazine utiles comme medicaments
FR2742749B1 (fr) Nouvelles phenylimidazolidines comportant notamment un radical nitrooxy ou carbonyloxy, procede et intermediaires de preparation, application comme medicaments, nouvelles utilisations et compositions pharmaceutiques
ES8604128A1 (es) Un procedimiento para la preparacion de nuevos derivados de bencenosulfonamida
ES2154266T3 (es) Amidas de acido sulfonamidocarbonilpiridin-2-carboxilico y su empleo como medicamentos.
FR2354091A1 (fr) Utilisation d'esters aliphatiques d'acide 2-methyl-2-alkylalcanoiques comme matieres aromatiques et compositions de parfums en contenant
ES8606282A1 (es) Un procedimiento de preparar derivados de acidos quinolin- ynaftiridin-carboxilicos
SE8600413D0 (sv) Nytt lekemedel och sett att framstella detsamma
HUP9802757A2 (hu) Új naftalénszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
FR2415630A1 (fr) Nouvelles 5-vinyl-2-pyrrolidones, utiles notamment dans la preparation des acides 4-amino-5-hexenoique et 4-amino-5-hexynoique, et leur preparation
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
ZA806399B (en) New 2-hydroxyalkyl-3,4,5-trihydroxypiperidine compounds, their production and their medicinal use
FR2423485A1 (fr) Nouvelles 1,3-diaryl-2-imino-imidazolidines et 1,3-diaryl-2-imino-hexahydro-pyrimidines substituees, procedes de preparation de ces composes et medicaments les contenant
FR2443471A1 (fr) Derives du type thiazolidine de la progesterone utiles notamment comme precurseurs de medicaments antiacne et antiseborrhee
DE3476847D1 (en) A remedial or prophylactic agent for the treatment of seizures
ATE14312T1 (de) Phenolester.
FR2445329A1 (fr) Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 673931

Country of ref document: ES